ClassID:

92750

C07C233/25 - CPC Classification

Classification description:

Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton

Recent Application in this class:
#1
20260021124
2026-01-22

BUDESONIDE 21-PHOSPHATE SALTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

#2
20260008792
2026-01-08

PROCESSES AND COMPOUNDS

#3
20250179059
2025-06-05

ANTICANCER COMPOUNDS

#4
20240360131
2024-10-31

BIARYL KINASE INHIBITORS

#5
20240343680
2024-10-17

PROCESS FOR PREPARING ACYL DERIVATIVES

#6
20240092725
2024-03-21

ALPHA-TRUXILLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF

#7
20230337677
2023-10-26

ARYL AND PYRIDYL AMIDE PESTICIDES AND COMPOSITIONS THEREOF

#8
20230286904
2023-09-14

INHIBITORS OF YAP/TAZ-TEAD ONCOPROTEINS, SYNTHESIS AND USE THEREOF

#9
20230257392
2023-08-17

INTERMEDIATE FOR SYNTHESIZING CAMPTOTHECIN DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF

#10
20230115869
2023-04-13

BUDESONIDE 21-PHOSPHATE SALTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

#11
20230025178
2023-01-26

Anticancer compounds

#12
20220251027
2022-08-11

Benzidine compound and application thereof

#13
20220211039
2022-07-07

METHOD OF CONTROLLING WEEDS IN A CULTIVATION AREA OF FIELD CORN

#14
20220162233
2022-05-26

PROCESSES AND COMPOUNDS

#15
20220096370
2022-03-31

HIGH PENETRATION COMPOSITION AND USES THEREOF

#16
20210337796
2021-11-04

METHOD OF CONTROLLING WEEDS IN A CULTIVATION AREA OF FIELD CORN

#17
20210277001
2021-09-09

Biaryl kinase inhibitors

#18
20210238192
2021-08-05

VASCULAR ADHESION PROTEIN-1 (VAP-1) MODULATORS AND THERAPEUTIC USES THEREOF

#19
20210179535
2021-06-17

Alpha-truxillic acid derivatives and pharmaceutical compositions thereof

#20
20200323207
2020-10-15

Method of controlling weeds in a cultivation area of field corn

#21
20200317671
2020-10-08

Biaryl kinase inhibitors

#22
20200308109
2020-10-01

FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF

#23
20200262784
2020-08-20

Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration

#24
20200157126
2020-05-21

Carbonate prodrugs and methods of using the same

#25
20200157039
2020-05-21

Process for converting S-enantiomer to its racemic form

#26
20200155609
2020-05-21

COMPOSITIONS AND METHODS OF MAKING EXPANDED HEMATOPOIETIC STEM CELLS USING PTEN INHIBITORS

#27
20200055809
2020-02-20

N-(7-fluoro-1,1,3-trimethyl -1 H-inden-4yl) amides and a process for preparing same

#28
20190367508
2019-12-05

Biaryl kinase inhibitors

#29
20190262497
2019-08-29

Therapeutic acrylates as enhanced medical adhesives

#30
20190177271
2019-06-13

FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF

#31
20190169130
2019-06-06

MULTIPLE-COMPONENT SOLID PHASES CONTAINING AT LEAST ONE ACTIVE PHARMACEUTICAL INGREDIENT

#32
20190169122
2019-06-06

Compositions and methods for treatment of prostate carcinoma

#33
20190111031
2019-04-18

Analgesic compounds

#34
20190092716
2019-03-28

Process for converting S-enantiomer to its racemic form

#35
20190062261
2019-02-28

Alpha-truxillic acid derivatives and pharmaceutical compositions thereof

#36
20190048006
2019-02-14

Biaryl kinase inhibitors

#37
20190016670
2019-01-17

Trifluoromethoylation of arenes via intramolecular trifluoromethoxy group migration

#38
20180362446
2018-12-20

Process for preparing biphenylamines from anilides by ruthenium catalysis

#39
20180237379
2018-08-23

Substituted malonamides and their use as antibacterial drugs

#40
20180195005
2018-07-12

Polymerizable polar compound, liquid crystal composition and liquid crystal display device

#41
20180134704
2018-05-17

Biaryl kinase inhibitors

#42
20180110861
2018-04-26

Curcumin conjugates and methods of use thereof

#43
20180099924
2018-04-12

Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide

#44
20180086778
2018-03-29

Carbonate prodrugs and methods of using the same

#45
20180079723
2018-03-22

Monocyclic compound

#46
20180016202
2018-01-18

OBSCURANT COMPOSITIONS

#47
20170362182
2017-12-21

MULTIPLE-COMPONENT SOLID PHASES CONTAINING AT LEAST ONE ACTIVE PHARMACEUTICAL INGREDIENT

#48
20170305846
2017-10-26

2,2′-diaminobiaryls having a phthaloyl group or succinoyl group

#49
20170298008
2017-10-19

Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration

#50
20170291871
2017-10-12

2,2′-diaminobiaryls having one primary and one secondary amine

#51
20170283374
2017-10-05

Compositions and methods for treatment of prostate carcinoma

#52
20170183340
2017-06-29

Biaryl kinase inhibitors

#53
20170174618
2017-06-22

Efficient synthesis of amines and amides from alcohols and aldehydes by using cascade catalysis

#54
20170151337
2017-06-01

High penetration composition and uses thereof

#55
20170114070
2017-04-27

INHIBITORS OF THE WNT SIGNALLING PATHWAYS

#56
20170036969
2017-02-09

NITRIFICATION INHIBITORS

#57
20170035709
2017-02-09

Method of treating pain using an acetaminophen dimer ether-linked through phenolic hydroxyl groups

#58
20170008922
2017-01-12

Branched chain-containing aromatic compound

#59
20170008916
2017-01-12

Carbonate prodrugs and methods of using the same

#60
20160368932
2016-12-22

Buprenorphine dimer and its use in treatment of gastrointestinal disorders

#61
20160214926
2016-07-28

DIPHENYLOXYALKYLAMINE DERIVATIVES AND ARYLOXYALKYLAMINE DERIVATIVES, PHARMACEUTICAL COMPOSITION, USE OF SAID PHARMACEUTICAL COMPOSITION FOR TREATING, PREVENTING OR INHIBITING CHRONIC PULMONARY INFLAMMATORY DISEASES AND METHOD FOR TREATING OR PREVENTING SUCH DISEASES

#62
20160145198
2016-05-26

COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS

#63
20160060212
2016-03-03

Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide

#64
20160045462
2016-02-18

Methods of treating pain or fever using pharmaceutically active acetaminophen dimers linked through phenolic hydroxyl groups

#65
20160038481
2016-02-11

Use of buprenorphine dimer in the treatment of peripheral neuropathic pain

#66
20160016927
2016-01-21

Dihydrobenzofuran derivatives as insecticidal compounds

#67
20150368187
2015-12-24

Inhibitors of the tumor necrosis factor receptor complex

#68
20150359791
2015-12-17

Composition for treatment of pathogens that are resistant to tetracyclines

#69
20150307504
2015-10-29

Buprenorphine dimer and its use in treatment of gastrointestinal disorders

#70
20150291508
2015-10-15

PROCESS FOR THE PREPARATION OF CRYSTALLINE FORM OF AGOMELATINE

#71
20150250793
2015-09-10

BAX agonist, compositions, and methods related thereto

#72
20150183737
2015-07-02

COMPOSITIONS AND METHODS FOR SUBSTRATE-SELECTIVE INHIBITION OF ENDOCANNABINOID OXYGENATION

#73
20150148419
2015-05-28

Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide

#74
20150148301
2015-05-28

Inhibitors of the activity of complex (III) of the mitochondrial electron transport chain and use thereof

#75
20150080472
2015-03-19

Treatment of friedreich's ataxia using histone deacetylase inhibitors

#76
20150011621
2015-01-08

Formylated xanthocillin analogues as neuroprotective agents

#77
20140343151
2014-11-20

Leukotriene Bantagonist compound

#78
20140243522
2014-08-28

Herbicidal benzoxazinones

#79
20140228443
2014-08-14

Compounds for treating ophthalmic diseases and disorders

#80
20140178374
2014-06-26

BAX agonist, compositions, and methods related thereto

#81
20140162989
2014-06-12

Multiple-component solid phases containing at least one active pharmaceutical ingredient

#82
20140135397
2014-05-15

Halogenated phenols for diagnostics, antioxidant protection and drug delivery

#83
20140134105
2014-05-15

Halogenated phenols for diagnostics, antioxidant protection and drug delivery

#84
20140051887
2014-02-20

Pharmaceutically acceptable cocrystals of N-[2-(7-methoxyl-1-naphtyl)ethyl]acetamide and methods of their preparation

#85
20130281652
2013-10-24

Functionalized phenolic compounds and polymers therefrom

#86
20130274240
2013-10-17

Fluorene compound and pharmaceutical use thereof

#87
20130230542
2013-09-05

ROS-activated compounds as selective anti-cancer therapeutics

#88
20130225596
2013-08-29

Heterocyclic derivative and pharmaceutical composition comprising the same

#89
20130101684
2013-04-25

Compounds, Compositions, And Methods For Reducing Or Eliminating Bitter Taste

#90
20130046111
2013-02-21

Method for the hydrolysis of substituted formylamines into substituted amines

#91
20130041106
2013-02-14

Chemoselective enrichment for compound isolation

#92
20130022549
2013-01-24

Halogenated phenols for diagnostics, antioxidant protection and drug delivery

#93
20130018026
2013-01-17

HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY

#94
20130017163
2013-01-17

HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY

#95
20120329869
2012-12-27

Benzyloxy anilide derivatives useful as potassium channel modulators

#96
20120183468
2012-07-19

Water-soluble functionalized fullerenes

#97
20120108670
2012-05-03

FORMOTEROL TARTRATE PROCESS AND POLYMORPH

#98
20120100991
2012-04-26

Herbicidal benzoxazinones

#99
20120065423
2012-03-15

Reactive distillation process for preparation of acetaminophen

#100
20120059149
2012-03-08

Branched chain-containing aromatic compound

#101
20120029237
2012-02-02

Autocatalytic process for the synthesis of chiral propargylic alcohols

#102
20120004405
2012-01-05

COMPOUNDS HAVING ACTIVITY IN CORRECTING MUTANT CFTR CELLULAR PROCESSING

#103
20110288066
2011-11-24

Phenoxy acetic acid derivatives

#104
20110263526
2011-10-27

Nitric Oxide Releasing Prodrugs of Therapeutic Agents

#105
20110245335
2011-10-06

NEW INHIBITORS FOR TREATING DISEASES ASSOCIATED WITH AN EXCESS TRANSPORT OF HYALURONAN

#106
20110245192
2011-10-06

NEW ACTIVATORS FOR TREATING AND/OR PREVENTING DISEASES OR MEDICAL CONDITIONS WHICH BENEFIT FROM AN INCREASED TRANSPORT OF HYALURONAN ACROSS A LIPID BILAYER

#107
20110212927
2011-09-01

Carbonate prodrugs and methods of using the same

#108
20110178108
2011-07-21

Group of amino substituted benzoyl derivatives and their preparation and their use

#109
20110160228
2011-06-30

DIHYDRO-ISO-CA-4 AND ANALOGUES: POTENT CYTOTOXICS, INHIBITORS OF TUBULIN POLYMERIZATION

#110
20110130554
2011-06-02

Process for the glycosidation of colchicine and thiocolchicine

#111
20110130438
2011-06-02

Aniline analogs as glycogen synthase activators

#112
20110124559
2011-05-26

Compounds as antagonists or inverse agonists at opioid receptors

#113
20110105571
2011-05-05

Opioid receptor antagonists

#114
20110021562
2011-01-27

TREATMENT OF FRIEDREICH'S ATAXIA USING HISTONE DEACETYLASE INHIBITORS

#115
20100317854
2010-12-16

NOVEL AMINODICARBOXYLIC ACID DERIVATIVES HAVING PHARMACEUTICAL PROPERTIES

#116
20100311974
2010-12-09

Substituted pyrazinecarboxylic acid anilide derivatives or salts thereof, intermediates of the same, pesticides for agricultural and horticultural use, and usage thereof

#117
20100249459
2010-09-30

Formoterol tartrate process and polymorph

#118
20100240634
2010-09-23

Fluorene compound and pharmaceutical use thereof

#119
20100234472
2010-09-16

Nitric oxide releasing derivatives of paracetamol

#120
20100204336
2010-08-12

Formoterol tartrate process and polymorph

#121
20100144884
2010-06-10

3-phenyl acrylic acid compound activators of type PPAR receptors and pharmaceutical/cosmetic compositions comprised thereof

#122
20100113592
2010-05-06

Unsymmetrical aromatic ether diacids and absorbable polymers therefrom

#123
20100113539
2010-05-06

Compounds for treating ophthalmic diseases and disorders

#124
20100041905
2010-02-18

Process for the Preparation of Substituted 2-Acetylamino-Alkoxyphenyl

#125
20090326263
2009-12-31

Process for the preparation of aniline-derived thyroid receptor ligands

#126
20090326059
2009-12-31

Benzyloxy anilide derivatives useful as potassium channel modulators

#127
20090253659
2009-10-08

Cycloalkylidene compounds as modulators of estrogen receptor

#128
20090239951
2009-09-24

Crystalline Material

#129
20090227649
2009-09-10

Management of Ophthalmologic Disorders, Including Macular Degeneration

#130
20090221703
2009-09-03

HIGH PENETRATION COMPOSITION AND USES THEREOF

#131
20090215765
2009-08-27

Methods of identifying neuroprotective compounds for retinal ganglion cells

#132
20090203906
2009-08-13

Aminodicarboxylic acid derivatives having pharmaceutical properties

#133
20090176815
2009-07-09

Novel Tricyclic Spiropiperidine Compounds, Their Synthesis and Their Uses as Modulators of Chemokine Receptor Activity

#134
20090170941
2009-07-02

Pharmaceutical compounds

#135
20090170927
2009-07-02

Functionalized sinapic acid and methyl sinapate

#136
20090163715
2009-06-25

Intermediate in Production of [2-(3,3,5,5-Tetramethylcyclohexyl)phenyl]Piperazine Compound

#137
20090156862
2009-06-18

Formoterol tartrate process and polymorph

#138
20090143622
2009-06-04

Method for the synthesis of substituted formylamines and substituted amines

#139
20090143594
2009-06-04

Process for the catalytic synthesis of diaryl ethers

#140
20090101519
2009-04-23

FLOW-TYPE LABORATORY OZONOLYSIS APPARATUS AND METHOD OF PERFORMING OZONOLYSIS REACTION

#141
20090075952
2009-03-19

NITRODERVIATIVES AS DRUGS FOR DISEASES HAVING AN INFLAMMATORY BASIS

#142
20090042929
2009-02-12

11-Beta-Hydroxysteroid Dehydrogenase Inhibitors

#143
20080269324
2008-10-30

Management of Ophthalmologic Disorders, Including Macular Degeneration

#144
20080262011
2008-10-23

Modulator

#145
20080207701
2008-08-28

Opioid receptor antagonists

#146
20080194835
2008-08-14

Methods for the manufacture of biphenyl amines

#147
20080194651
2008-08-14

Nitroderivatives as drugs for diseases having an inflammatory basis

#148
20080188654
2008-08-07

Compounds for treatment of inflammation, diabetes and related disorders

#149
20080176952
2008-07-24

Management of Ophthalmologic Disorders, Including Macular Degeneration

#150
20080167332
2008-07-10

Novel Compounds 243

#151
20080161575
2008-07-03

Process for the synthesis of 6-amino-4-(3-chloro-4-fluorophenylamino)-7-ethoxyquinoline-3-carbonitrile

#152
20080132459
2008-06-05

Inhibitors of histone deacetylase

#153
20080119539
2008-05-22

Therapeutic amides

#154
20080114187
2008-05-15

Formoterol tartrate process and polymorph

#155
20080112899
2008-05-15

Carboxamides and Their Use

#156
20080064884
2008-03-13

Novel Process 1

#157
20080064708
2008-03-13

Substituted pyrazinecarboxylic acid anilide derivatives or salts thereof, intermediates of the same, pesticides for agricultural and horticultural use, and usage thereof

#158
20080058314
2008-03-06

Dicarboxylic acid derivatives with pharmaceutical properties

#159
20080051596
2008-02-28

6-(poly-substituted aryl)-4-aminopicolinates and their use as herbicides

#160
20080045734
2008-02-21

6-(poly-substituted aryl)-4-aminopicolinates and their use as herbicides

#161
20080045598
2008-02-21

Sulfonanilide analogs as selective aromatase modulators (SAMs)

#162
20080045483
2008-02-21

Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes

#163
20080031823
2008-02-07

Agents for therapy efficacy monitoring and deep tissue imaging

#164
20080004251
2008-01-03

Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor

#165
20070276138
2007-11-29

Modulators of peroxisome proliferator activated receptors

#166
20070276000
2007-11-29

Naphthalene compounds as selective estrogen receptor modulators

#167
20070259961
2007-11-08

Compounds for treatment of inflammation, diabetes and related disorders

#168
20070238882
2007-10-11

Process for preparing nitrooxy esters, nitrooxy thioesters nitrooxy carbonates and nitrooxy thiocarbinates, intermediates useful in said process and preparation thereof

#169
20070238783
2007-10-11

β-Benzyloxyaspartate derivatives with amino group on benzene ring

#170
20070219244
2007-09-20

Histone deacetylase inhibitors as therapeutics for neurological diseases

#171
20070213348
2007-09-13

Cycloalkylidene compounds as modulators of estrogen receptor

#172
20070197499
2007-08-23

Pharmaceutical compounds

#173
20070191640
2007-08-16

Process for the synthesis of substituted alpha-aminoindan derivatives

#174
20070179060
2007-08-02

6-(poly-substituted aryl)-4-aminopicolinates and their use as herbicides

#175
20070155839
2007-07-05

Cycloalkylidene compounds as modulators of estrogen receptor

#176
20070155813
2007-07-05

Hsp90 family protein inhibitors

#177
20070149801
2007-06-28

Process for the preparation of nitrooxyderivatives of paracetamol

#178
20070142445
2007-06-21

4-(3,3-dihalo-allyloxy) phenoxy alkyl derivatives

#179
20070141113
2007-06-21

Unsymmetrical aromatic ether diacids and absorbable polymers therefrom

#180
20070135497
2007-06-14

Biphenyl derivative or its salt, and pesticide containing it as an active ingredient

#181
20070066658
2007-03-22

Diphenylether amide derivatives as opioid receptor antagonists

#182
20070054888
2007-03-08

NOVEL SUBSTITUTED DIAMINE DERIVATIVES USEFUL AS MOTILIN AGONISTS

#183
20070037985
2007-02-15

Process for the preparation of -substituted formamides

#184
20070026078
2007-02-01

Pharmaceutical co-crystal compositions

#185
20060264507
2006-11-23

Formoterol tartrate process and polymorph

#186
20060223794
2006-10-05

Novel olanzapine forms and related methods of treatment

#187
20060189804
2006-08-24

Synthetic method for the preparation of quinazolin-4-one derivative

#188
20060183741
2006-08-17

Substituted diamine derivatives useful as motilin antagonists

#189
20060173211
2006-08-03

Binaphthol derivatives and their use in optical resolution or optical transformation

#190
20060173204
2006-08-03

New 3-aryl propionic acid derivatives and analogs

#191
20060173058
2006-08-03

KCNQ channel modulating compounds and their pharmaceutical use

#192
20060094769
2006-05-04

Aminodicarboxylic acid derivatives having pharmaceutical properties

#193
20060094757
2006-05-04

Substantially pure cilostazol and processes for making same

#194
20060094756
2006-05-04

Substantially pure cilostazol and processes for making same

#195
20060069078
2006-03-30

Management of ophthalmologic disorders, including macular degeneration

#196
20060052638
2006-03-09

One-pot reductive acetamidation of aryl nitro compounds

#197
20060040979
2006-02-23

3-Aryl-2-hydroxypropionic acid derivative I

#198
20060025474
2006-02-02

Bisphenyl compounds useful as vitamin D3 receptor agonists

#199
20050283019
2005-12-22

N-acylamino benzyl ether derivatives

#200
20050272036
2005-12-08

Ketones

#201
20050267168
2005-12-01

Pentanoic acid derivatives

#202
20050267167
2005-12-01

Pentanoic acid derivatives

#203
20050261371
2005-11-24

Pentanoic acid derivatives

#204
20050256201
2005-11-17

Phenethanolamine derivatives

#205
20050250822
2005-11-10

Substituted benzanilide compound and noxious organism controlling agent

#206
20050245583
2005-11-03

4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives

#207
20050209333
2005-09-22

Malonamic acids and derivatives thereof as thyroid receptor ligands

#208
20050187284
2005-08-25

Integrin receptor inhibitors

#209
20050148667
2005-07-07

Formoterol tartrate polymorph

#210
20050148584
2005-07-07

Substituted diamine derivatives useful as motilin antagonists

#211
20050113580
2005-05-26

Compounds and methods

#212
20050107448
2005-05-19

Calcium receptor antagonists

#213
20050085541
2005-04-21

Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof

#214
20050065343
2005-03-24

Substantially pure cilostazol and processing for making same

#215
20050065181
2005-03-24

Process for the synthesis of 6-amino-4-(3-chloro-4-fluoro-phenylamino)-7-ethoxy-quinoline-3-carbonitrile

#216
20050054873
2005-03-10

Process for the preparation of aniline-derived thyroid receptor ligands

#217
20050054727
2005-03-10

Phenyl naphthol ligands for thyroid hormone receptor

#218
20050038122
2005-02-17

Phenyl naphthol ligands for thyroid hormone receptor

#219
20050032890
2005-02-10

Aniline-derived ligands for the thyroid receptor

#220
20050020684
2005-01-27

Modulators of peroxisome proliferator activated receptors

#221
17065025
2021-01-12

Chemosensitization of resistant by synthetically related compounds

#222
16736128
2020-11-24

Chemosensitization of resistant by synthetically related compounds

#223
14216188
2017-08-15

System for crystalizing chemical compounds and methodologies for utilizing the same